临床缓解预测者在非殖民支气管和严重喘与2型向生物疗法:一个追溯的现实生活试点研究
Vitaliano Nicola Quaranta1, Andrea Portacci1, Francesca Montagnolo1
1Respiratory Diseases, University of Bari, 70121 Bari, Italy.
Journal of clinical medicine
|November 9, 2024
概括
对于患有严重喘和支气管切除症的患者,基线FEV1是2型生物药物缓解的关键预测指标. 超过72.5%的FEV1表明实现临床缓解的可能性更高.
科学领域:
- 肺部病理学 肺部病理学
- 临床医学 临床医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的喘 (SA) 和非囊性纤维化支气管支气管 (BE) 没有殖民是研究不足的.
- 2型向生物疗法为这一群体提供了潜在的治疗方法.
- 预测这些疗法临床缓解的预测因素尚未确定.
研究的目的:
- 为了确定预测SA和非殖民BE患者临床缓解的因素.
- 在这个队列中评估2型向生物疗法的疗效.
主要方法:
- 对14名SA和非殖民BE患者的回顾性分析.
- 在12个月后使用意大利严重喘网络 (SANI) 标准评估的临床缓解.
- 后勤回归和ROC曲线分析用于预测器识别 (FEV1,FVC).
主要成果:
- 28.6%的患者在12个月后实现了临床缓解.
- 较高的基线FEV1与缓解显著相关 (92.25%与65.10%,p=0.034).
- 基线FEV1预测缓解 (OR=1.008,p=0.050);FEV1截止值为72.5%显示出高预测精度 (AUC=0.900,p=0.024).
结论:
- FEV1是SA和非殖民的BE患者在2型生物制剂上的临床缓解的关键预测指标.
- 基线FEV1为72.5%可以指导临床医生在患者选择中获得最佳结果.
- 保持肺功能对于这种复杂的患者群体的治疗成功至关重要.
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
182
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
182
01:17Drugs Used in Lower Respiratory Disorders: Overview
353
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
353
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
96
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
96
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
222
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
222
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K